Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03210649 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT01983735 | Efficacy and Safety of TELMINUVO to Stage 2 Hypertension | ||
| NCT04224350 | Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) | ||
| NCT02631954 | Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers | ||
| NCT03671941 | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers | ||
| NCT04706286 | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT02916901 | Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers | ||
| NCT01910077 | Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg | ||
| NCT04478097 | Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers | ||
| NCT01663038 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination | ||
| NCT05657574 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT01071720 | The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 | ||
| NCT07577518 | Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome | ||
| NCT06643819 | Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes | ||
| NCT02977065 | To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors | ||
| NCT02005757 | Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) | ||
| NCT02501200 | CKD-391 Pharmacokinetic Study Phase I | ||
| NCT05881707 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg | ||
| NCT05673369 | Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition | ||
| NCT06709807 | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers | ||
| NCT02005744 | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function | ||
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT06916793 | A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia | ||
| NCT05043467 | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus | ||
| NCT03849287 | Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults | ||
| NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 | ||
| NCT02498509 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 | ||
| NCT04676893 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects | ||
| NCT04611932 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers | ||
| NCT01426100 | CKD-828 Telmisartan Non-Responder Trial | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT04019743 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers | ||
| NCT05921435 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults | ||
| NCT04156685 | Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 | ||
| NCT01001611 | An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus | ||
| NCT04952506 | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers | ||
| NCT04322032 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 | ||
| NCT02648854 | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | ||
| NCT03848637 | The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375 | ||
| NCT04471441 | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. | ||
| NCT01685671 | Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers | ||
| NCT06942156 | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT02066207 | CKD-337 Drug Interaction Study | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT05207761 | Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930 |
